Key points are not available for this paper at this time.
According to evaluations performed using the DEREK and WhichP450 modules, slight changes or substitutions in the piperazine ring during drug development could yield new derivatives with improved safety and metabolic stability compared to EST.
Attwa et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: